Congleton Jon 4
4 · Mineralys Therapeutics, Inc. · Filed Oct 15, 2024
Insider Transaction Report
Form 4
Congleton Jon
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2024-10-11$13.52/sh−15,271$206,433→ 895,941 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $13.35 to $13.76. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.